Mark J Hamblin Selected Research

Mark J Hamblin Research Topics

2	Idiopathic Pulmonary Fibrosis 11/2022 - 01/2019
1	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2023
1	Myositis (Idiopathic Inflammatory Myopathies) 04/2020
1	Disease Progression 12/2018
1	Neurosarcoidosis 11/2017
1	Sarcoidosis (Schaumann Disease) 11/2017
1	Fibrosis (Cirrhosis) 09/2014
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 09/2014
1	Lung Injury 09/2014
1	Virus Diseases (Viral Diseases) 05/2013
1	Inflammation (Inflammations) 05/2013

2	Monoclonal AntibodiesIBA 11/2022 - 11/2017
2	Hyaluronic Acid (Hyaluronan)IBA 09/2014 - 05/2013
1	AntigensIBA 01/2023
1	Fructose-Bisphosphate Aldolase (Aldolase)IBA 04/2020
1	AntibodiesIBA 04/2020
1	Antinuclear AntibodiesIBA 04/2020
1	Creatine Kinase (Creatine Phosphokinase)IBA 04/2020
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	PRM-151IBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2017
1	Infliximab (Remicade)FDA Link 11/2017
1	indium-bleomycinIBA 09/2014
1	Bleomycin (Blenoxane)FDA LinkGeneric 09/2014
1	Lovastatin (Mevacor)FDA LinkGeneric 09/2014
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 09/2014
1	ChemokinesIBA 09/2014
1	Interferon Type IIBA 05/2013

1	Therapeutics 12/2018